NYSE: AXTA
Axalta Coating Systems Ltd Stock

$30.87-0.37 (-1.18%)
Updated Jul 3, 2025
AXTA Price
$30.87
Fair Value Price
N/A
Market Cap
$6.75B
52 Week Low
$27.70
52 Week High
$41.66
P/E
15.06x
P/B
3.25x
P/S
1.38x
PEG
1.11x
Dividend Yield
N/A
Revenue
$5.24B
Earnings
$449.00M
Gross Margin
34.4%
Operating Margin
14.47%
Profit Margin
8.6%
Debt to Equity
2.55
Operating Cash Flow
$568M
Beta
1.1
Next Earnings
Jul 30, 2025
Ex-Dividend
N/A
Next Dividend
N/A

AXTA Overview

Axalta Coating Systems, Ltd. offers coatings for a wide variety of industrial applications, materials, and sectors, including automotive paints. It operates through two segments, Performance Coatings, and Transportation Coatings. Known as Axalta Coating Systems Bermuda Co., Ltd. until 2014/08, the company was founded in 1866 and is headquartered in Philadelphia, PA.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine AXTA's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Specialty Chemical

Industry Rating
D
AXTA
Ranked
#25 of 53

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$46.76A
$60.33B
$737.28B
View Top Specialty Chemical Stocks

Be the first to know about important AXTA news, forecast changes, insider trades & much more!

AXTA News

Overview

Due Diligence Score

Industry Average (34)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how AXTA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

AXTA ($30.87) is trading above its intrinsic value of $21.50, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
AXTA is good value based on its earnings relative to its share price (15.06x), compared to the US market average (30.96x)
P/E vs Market Valuation
AXTA is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more AXTA due diligence checks available for Premium users.

Valuation

AXTA price to earnings (PE)

For valuing profitable companies with steady earnings

Company
15.06x
Industry
8.56x
Market
30.96x
AXTA is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
AXTA is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

AXTA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
3.25x
Industry
3.44x
AXTA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

AXTA price to earnings growth (PEG)

For valuing profitable companies with growth potential

AXTA is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

AXTA's financial health

Profit margin

Revenue
$1.3B
Net Income
$99.0M
Profit Margin
7.8%
AXTA's Earnings (EBIT) of $759.00M... subscribe to Premium to read more.
Interest Coverage Financials
AXTA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$7.4B
Liabilities
$5.3B
Debt to equity
2.55
AXTA's short-term assets ($2.82B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AXTA's long-term liabilities ($3.96B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AXTA's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AXTA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$26.0M
Investing
-$44.0M
Financing
-$8.0M
AXTA's operating cash flow ($568.00M)... subscribe to Premium to read more.
Debt Coverage Financials

AXTA vs Specialty Chemical Stocks

TickerZen RatingMarket Cap1d %P/EP/B
AXTAC$6.75B-1.18%15.06x3.25x
NEUB$6.96B+2.39%14.68x4.58x
ESIC$5.82B-0.21%20.17x2.31x
ALBD$7.91B-1.15%-6.04x0.79x
BCPCB$5.38B+1.12%39.20x4.45x

Axalta Coating Systems Stock FAQ

What is Axalta Coating Systems's quote symbol?

(NYSE: AXTA) Axalta Coating Systems trades on the NYSE under the ticker symbol AXTA. Axalta Coating Systems stock quotes can also be displayed as NYSE: AXTA.

If you're new to stock investing, here's how to buy Axalta Coating Systems stock.

What is the 52 week high and low for Axalta Coating Systems (NYSE: AXTA)?

(NYSE: AXTA) Axalta Coating Systems's 52-week high was $41.66, and its 52-week low was $27.70. It is currently -25.89% from its 52-week high and 11.44% from its 52-week low.

How much is Axalta Coating Systems stock worth today?

(NYSE: AXTA) Axalta Coating Systems currently has 218,559,477 outstanding shares. With Axalta Coating Systems stock trading at $30.87 per share, the total value of Axalta Coating Systems stock (market capitalization) is $6.75B.

Axalta Coating Systems stock was originally listed at a price of $20.75 in Nov 12, 2014. If you had invested in Axalta Coating Systems stock at $20.75, your return over the last 10 years would have been 48.77%, for an annualized return of 4.05% (not including any dividends or dividend reinvestments).

How much is Axalta Coating Systems's stock price per share?

(NYSE: AXTA) Axalta Coating Systems stock price per share is $30.87 today (as of Jul 3, 2025).

What is Axalta Coating Systems's Market Cap?

(NYSE: AXTA) Axalta Coating Systems's market cap is $6.75B, as of Jul 5, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Axalta Coating Systems's market cap is calculated by multiplying AXTA's current stock price of $30.87 by AXTA's total outstanding shares of 218,559,477.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.